Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00408122
Other study ID # VF-20060109
Secondary ID
Status Completed
Phase N/A
First received December 5, 2006
Last updated October 15, 2014
Start date January 2007
Est. completion date January 2012

Study information

Verified date October 2014
Source Odense University Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics Committee
Study type Observational

Clinical Trial Summary

The aim of the study is to evaluate the diagnostic procedures emission tomography in combination with a CT scan (PET/CT) and endoscopic ultrasonography (EUS) in the preoperative evaluation of resectability of patients with primary or secondary liver cancers.


Recruitment information / eligibility

Status Completed
Enrollment 77
Est. completion date January 2012
Est. primary completion date January 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- all patients who are referred to The Department of Surgery, Odense University Hospital, for surgical treatment of suspected or biopsy proven primary or secondary liver cancer.

Exclusion Criteria:

- age less than 18 years

- patients who are not fit for liver surgery because of co-morbidity

- patients for whom the extra investigations in the study are considered to give an increased risk because of co-morbidity such as

- Patients with s-creatinin > 150 micromol/l

- Patients who take peroral antidiabetic drugs or have a poorly regulated diabetes mellitus

- patients who do not understand the patient information

- patients who do not want to participate

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
PET/CT scan and EUS


Locations

Country Name City State
Denmark Dept of Surgery, Odense university Hospital Odense

Sponsors (1)

Lead Sponsor Collaborator
Odense University Hospital

Country where clinical trial is conducted

Denmark, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05524155 - Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis Phase 2
Recruiting NCT02632201 - Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis Phase 1/Phase 2
Enrolling by invitation NCT01715402 - Optimization of Health Expenditure in Liver Surgery N/A
Recruiting NCT01035385 - Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC) Phase 3
Recruiting NCT05098847 - Cryoablation Combined With Sintilimab Plus Lenvatinib In Previously Treated Unresectable Liver Metastasis From Solid Tumors Phase 2
Withdrawn NCT02651090 - Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI Phase 3
Withdrawn NCT01775280 - Response of Hepatic Tumors to Radioembolization Phase 2
Completed NCT00068068 - Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases Phase 2
Terminated NCT02453490 - Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis Phase 3
Recruiting NCT04622423 - Advanced Therapies for Liver Metastases
Completed NCT00892424 - Sorafenib-RT Treatment for Liver Metastasis (SLIM) Phase 1/Phase 2
Completed NCT00028405 - Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors Phase 1
Completed NCT03801915 - Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers Phase 2
Completed NCT02218801 - A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program
Completed NCT01834014 - Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases N/A
Completed NCT00083785 - Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases Phase 2
Active, not recruiting NCT03428477 - EPA for Metastasis Trial 2 Phase 3
Completed NCT02316028 - Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC) Phase 1/Phase 2
Completed NCT01785212 - The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver N/A
Completed NCT03785210 - Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers Phase 2